• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers.宫颈上皮内瘤变的动态行为学解释与分子生物标志物
J Clin Pathol. 2006 Oct;59(10):1017-28. doi: 10.1136/jcp.2005.027839. Epub 2006 May 5.
2
Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.全自动p16/Ki-67双重染色在挪威宫颈癌筛查项目中对HPV阳性女性进行分流的临床价值
Cancer Cytopathol. 2017 Apr;125(4):283-291. doi: 10.1002/cncy.21807. Epub 2016 Dec 5.
3
Increased Ki-67 proliferative index and absence of P16INK4 in CIN-HPV related pathogenic pathways different from cervical squamous intraepithelial lesion.在与宫颈鳞状上皮内病变不同的CIN-HPV相关致病途径中,Ki-67增殖指数增加且P16INK4缺失。
Br J Ophthalmol. 2006 Jul;90(7):894-9. doi: 10.1136/bjo.2005.086314. Epub 2006 Mar 15.
4
Comparison of the sensitivity and specificity of p16/Ki-67 dual staining and HPV DNA testing of abnormal cervical cytology in the detection of histology proven cervical intraepithelial neoplasia grade 2 and above (CIN 2+).p16/Ki-67双重染色与HPV DNA检测对异常宫颈细胞学检查在检测组织学证实的2级及以上宫颈上皮内瘤变(CIN 2+)中的敏感性和特异性比较。
Malays J Pathol. 2017 Dec;39(3):257-265.
5
Dual immunostaining of cervical cytology specimens with atypical squamous cells for p16/Ki-67 does not exclude the existence of a high-grade squamous intraepithelial lesion.对不典型鳞状细胞进行 p16/Ki-67 的双重免疫染色并不能排除高级别鳞状上皮内病变的存在。
Virchows Arch. 2013 Nov;463(5):689-96. doi: 10.1007/s00428-013-1483-4. Epub 2013 Oct 1.
6
Differentiating high-grade cervical intraepithelial lesion from atrophy in postmenopausal women using Ki-67, cyclin E, and p16 immunohistochemical analysis.利用Ki-67、细胞周期蛋白E和p16免疫组化分析鉴别绝经后女性的高级别宫颈上皮内瘤变与萎缩
J Low Genit Tract Dis. 2005 Apr;9(2):100-7. doi: 10.1097/00128360-200504000-00006.
7
Using p16 immunohistochemistry to classify morphologic cervical intraepithelial neoplasia 2: correlation of ambiguous staining patterns with HPV subtypes and clinical outcome.使用p16免疫组化对形态学上的宫颈上皮内瘤变2级进行分类:不明确染色模式与HPV亚型及临床结局的相关性
Hum Pathol. 2017 Aug;66:144-151. doi: 10.1016/j.humpath.2017.06.014. Epub 2017 Jul 11.
8
Ki-67 quantitative evaluation as a marker of cervical intraepithelial neoplasia and human papillomavirus infection.Ki-67 定量评估作为宫颈上皮内瘤变和人乳头瘤病毒感染的标志物。
Int J Gynecol Cancer. 2010 Jan;20(1):116-9. doi: 10.1111/IGC.0b013e3181bc8da7.
9
Relationship between the presence of oncogenic HPV DNA assessed by polymerase chain reaction and Ki-67 immunoquantitative features in cervical intraepithelial neoplasia.聚合酶链反应评估的致癌性人乳头瘤病毒(HPV)DNA的存在与宫颈上皮内瘤变中Ki-67免疫定量特征之间的关系。
J Pathol. 2001 Dec;195(5):557-62. doi: 10.1002/path.998.
10
Quantitative molecular parameters to identify low-risk and high-risk early CIN lesions: role of markers of proliferative activity and differentiation and Rb availability.用于识别低风险和高风险早期宫颈上皮内瘤变病变的定量分子参数:增殖活性、分化标志物及Rb可用性的作用
Int J Gynecol Pathol. 2004 Apr;23(2):100-9. doi: 10.1097/00004347-200404000-00003.

引用本文的文献

1
The role of HR-HPV integration in the progression of premalignant lesions into different cancer types.高危型人乳头瘤病毒(HR-HPV)整合在癌前病变进展为不同癌症类型过程中的作用。
Heliyon. 2024 Jul 22;10(15):e34999. doi: 10.1016/j.heliyon.2024.e34999. eCollection 2024 Aug 15.
2
Impact of CD44 genetic variants on clinicopathological characteristics of uterine cervical cancer patients.CD44 基因变异对宫颈癌患者临床病理特征的影响。
Int J Med Sci. 2024 May 27;21(8):1428-1437. doi: 10.7150/ijms.96414. eCollection 2024.
3
Association between p16/Ki-67 dual stain cytology results prior to and 6 months after LLETZ treatment for CIN and the follow-up regimen three years after treatment: a retrospective cohort study.宫颈上皮内瘤变(CIN)患者 LLETZ 治疗前后 6 个月 p16/Ki-67 双染细胞学结果与治疗后 3 年随访方案的相关性:一项回顾性队列研究。
Arch Gynecol Obstet. 2024 Jul;310(1):493-499. doi: 10.1007/s00404-024-07553-8. Epub 2024 May 28.
4
p16 flow cytometry of exfoliated cervical cells: Its role in quantitative pathology and clinical diagnosis of squamous intraepithelial lesions.巴氏涂片宫颈细胞的 p16 流式细胞术:在鳞状上皮内病变的定量病理学和临床诊断中的作用。
Clin Transl Med. 2023 Mar;13(3):e1209. doi: 10.1002/ctm2.1209.
5
The impact of Aurora kinase A genetic polymorphisms on cervical cancer progression and clinicopathologic characteristics.极光激酶 A 基因多态性对宫颈癌进展及临床病理特征的影响。
Int J Med Sci. 2021 Apr 22;18(11):2457-2465. doi: 10.7150/ijms.58516. eCollection 2021.
6
Endogenous YAP1 activation drives immediate onset of cervical carcinoma in situ in mice.内源性 YAP1 激活导致小鼠宫颈原位癌的即刻发生。
Cancer Sci. 2020 Oct;111(10):3576-3587. doi: 10.1111/cas.14581. Epub 2020 Aug 21.
7
Investigation of metastasis-associated in colon cancer-1 genetic variants in the development and clinicopathologcial characteristics of uterine cervical cancer in Taiwanese women.探讨结肠癌转移相关基因 1 (MACC1)在台湾女性宫颈癌的发生发展及临床病理特征中的作用。
Int J Med Sci. 2020 Feb 4;17(4):490-497. doi: 10.7150/ijms.40204. eCollection 2020.
8
Toward development of a large field-of-view cancer screening patch (CASP) to detect cervical intraepithelial neoplasia.致力于开发一种用于检测宫颈上皮内瘤变的大视野癌症筛查贴片(CASP)。
Biomed Opt Express. 2019 Nov 6;10(12):6145-6159. doi: 10.1364/BOE.10.006145. eCollection 2019 Dec 1.
9
The clinicopathological characteristic associations of long non-coding RNA gene H19 polymorphisms with uterine cervical cancer.长链非编码RNA基因H19多态性与子宫颈癌的临床病理特征关联
J Cancer. 2019 Oct 15;10(25):6191-6198. doi: 10.7150/jca.36707. eCollection 2019.
10
On-chip immunofluorescence analysis of single cervical cells using an electroactive microwell array with barrier for cervical screening.使用带有屏障的电活性微孔阵列对单个宫颈细胞进行片上免疫荧光分析用于宫颈筛查。
Biomicrofluidics. 2019 Jul 30;13(4):044107. doi: 10.1063/1.5089796. eCollection 2019 Jul.

本文引用的文献

1
HPV-mediated cervical carcinogenesis: concepts and clinical implications.人乳头瘤病毒介导的宫颈癌发生:概念与临床意义
J Pathol. 2006 Jan;208(2):152-64. doi: 10.1002/path.1866.
2
Human leukocyte antigen class I and II haplotypes and risk of cervical cancer.人类白细胞抗原I类和II类单倍型与宫颈癌风险
Tissue Antigens. 2005 Oct;66(4):321-4. doi: 10.1111/j.1399-0039.2005.00478.x.
3
Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study.一项前瞻性人群研究中持续性高危型人乳头瘤病毒感染与宫颈肿瘤发生的相关性
J Clin Pathol. 2005 Sep;58(9):946-50. doi: 10.1136/jcp.2004.022863.
4
Potential of telomerase expression and activity in cervical specimens as a diagnostic tool.宫颈标本中端粒酶表达及活性作为诊断工具的潜力。
J Clin Pathol. 2005 Sep;58(9):911-4. doi: 10.1136/jcp.2004.024158.
5
Combined p53 and retinoblastoma protein detection identifies persistent and regressive cervical high-grade squamous intraepithelial lesions.联合检测p53和视网膜母细胞瘤蛋白可识别持续性和消退性宫颈高级别鳞状上皮内病变。
Am J Surg Pathol. 2005 Aug;29(8):1062-6.
6
Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype.高级别宫颈发育异常的自然消退:人乳头瘤病毒类型和HLA表型的影响
Clin Cancer Res. 2005 Jul 1;11(13):4717-23. doi: 10.1158/1078-0432.CCR-04-2599.
7
Genomics and proteomics--the way forward.
Ann Oncol. 2005;16 Suppl 2:ii30-44. doi: 10.1093/annonc/mdi728.
8
[Molecular pathogenesis of cervical cancer and its first steps].
Pathologe. 2005 Jul;26(4):283-90. doi: 10.1007/s00292-005-0763-4.
9
HPV-mediated transformation of the anogenital tract.人乳头瘤病毒介导的肛门生殖道转化。
J Clin Virol. 2005 Mar;32 Suppl 1:S25-33. doi: 10.1016/j.jcv.2004.11.019.
10
The epidemiology of human papillomavirus infections.人乳头瘤病毒感染的流行病学
J Clin Virol. 2005 Mar;32 Suppl 1:S16-24. doi: 10.1016/j.jcv.2004.12.008.

宫颈上皮内瘤变的动态行为学解释与分子生物标志物

Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers.

作者信息

Baak J P A, Kruse A-J, Robboy S J, Janssen E A M, van Diermen B, Skaland I

机构信息

Stovagen University Hospital and the Gade Institute, University of Bergen, Bergen, Norway.

出版信息

J Clin Pathol. 2006 Oct;59(10):1017-28. doi: 10.1136/jcp.2005.027839. Epub 2006 May 5.

DOI:10.1136/jcp.2005.027839
PMID:16679355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1861745/
Abstract

The microscopic phenotype of cervical intraepithelial neoplasia (CIN) reflects a fine balance between factors that promote or reduce CIN development. A shortcoming of the current grading system is its reliance on static morphology and microscopic haematoxylin-eosin features of the epithelium alone. In reality, CIN is a dynamic process, and the epithelium may exhibit differing results over time. Functional biomarkers p16, Ki-67, p53, retinoblastoma protein cytokeratin (CK)14 and CK13, help in the assessment of an individual CIN's lesion's potential for progression and regression. The aggregate information provided by these biomarkers exceeds the value of the classic grading system. Consequently, many more CINs that will either regress or progress can be accurately identified. These findings agree with known molecular interactions between HPV and the host. For accurate interpretation of a CIN, it is essential that these biomarkers be determined quantitatively and separately in the superficial, middle and deep layers of the epithelium. Such geography-specific epithelial evaluations of quantitative biomarkers emphasise the dynamic nature of a particular CIN lesion, thereby changing the art of static morphology grading into dynamic interpretation of the diseased tissue, with a strong prognostic effect.

摘要

宫颈上皮内瘤变(CIN)的微观表型反映了促进或减少CIN发展的因素之间的微妙平衡。当前分级系统的一个缺点是仅依赖于上皮细胞的静态形态学和微观苏木精-伊红特征。实际上,CIN是一个动态过程,随着时间的推移上皮细胞可能会呈现出不同的结果。功能性生物标志物p16、Ki-67、p53、视网膜母细胞瘤蛋白、细胞角蛋白(CK)14和CK13有助于评估个体CIN病变的进展和消退潜力。这些生物标志物提供的综合信息超过了经典分级系统的价值。因此,可以准确识别出更多将会消退或进展的CIN。这些发现与已知的人乳头瘤病毒(HPV)与宿主之间的分子相互作用相符。为了准确解读CIN,必须在上皮细胞的表层、中层和深层分别对这些生物标志物进行定量测定。这种针对特定部位上皮细胞的定量生物标志物评估强调了特定CIN病变的动态性质,从而将静态形态学分级的技术转变为对患病组织的动态解读,具有很强的预后效果。